OVERVIEW

VIP 6mg refers to Vasoactive Intestinal Peptide, a naturally occurring neuropeptide widely distributed throughout the body, particularly in the gastrointestinal tract, lungs, and central nervous system. VIP plays a key role in regulating smooth muscle relaxation, vasodilation, and secretion of water and electrolytes in the intestines. It also influences immune modulation and inflammatory responses. By binding to specific receptors (VPAC1 and VPAC2), VIP helps maintain balance in cardiovascular, respiratory, and digestive functions. Because of its broad physiological effects, it has been studied in research settings for conditions involving inflammation, pulmonary function, and certain immune-related disorders.

At a 6mg dosage, VIP is typically supplied as a lyophilized peptide for research or specialized clinical use and requires careful reconstitution and handling. Investigational studies suggest it may support respiratory health, promote vasodilation, and help regulate inflammatory pathways. However, VIP is a potent biologically active peptide, and improper dosing can lead to side effects such as flushing, low blood pressure, headache, or rapid heart rate. It is not widely approved for general medical use outside specific clinical or research applications. Due to its significant effects on cardiovascular and immune systems, administration should only occur under the supervision of a qualified healthcare professional with appropriate monitoring and guidance.